Bedinvetmab, CAS 2171034-69-6

Product Description: Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) targeting nerve growth factor (NGF). Bedinvetmab inhibits NGF interaction with tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR) receptors. Bedinvetmab can be used for the research of osteoarthritis pain in dogs[1][2].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Krautmann M, et, al. Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs. Vet J. 2021 Oct;276:105733. /[2]Corral MJ, et, al. A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis. Vet Anaesth Analg. 2021 Nov;48(6):943-955.

CAS Number: 2171034-69-6

Molecular Weight: N/A

Compound Purity: 99.80

Research Area: Inflammation/Immunology

Solubility: H2O

Target: Trk Receptor

• Artikelnummer: MEXHY-P99297-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99297-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK